Data & Analytics

As a severe energy crisis grips the world, the Egypt Energy Show sees new alliances form, positioning Cairo as a key player in global energy security.

Agena Bioscience's new test helps labs align with updated ACMG recommendations for cystic fibrosis, aiming for more equitable and efficient carrier screening.

A massive new dataset integrating brain scans, wearables, and biomarkers is now open to researchers, promising a new era for bipolar disorder treatment.

UFS, BankOnIT, and others merge into Navanta, a new powerhouse aiming to simplify technology and empower over 700 community financial institutions.

Universal Plant Services acquires engineering firm MSI, aiming to merge advanced diagnostics with field execution for a powerful end-to-end industrial solution.

A new alliance between E-Power and Raytel aims to solve AI's biggest bottlenecks by combining ultra-fast optics with advanced power grids.

Westcliff University opens a new Dallas campus, betting its career-focused model can supply the talent needed for the region's explosive economic growth.

A gene expression test is changing melanoma care by providing risk data beyond traditional staging, enabling more tailored treatment for patients.

New data shows Dizal's ZEGFROVY achieved an 81.3% response rate in a lung cancer subgroup with limited options, signaling a potential new first-line standard.

Estonian media firm Levira launches its UK base in Leeds, leveraging aql's data hub and strengthening the city's role as a key European tech link.

EnerSys will unveil its strategic framework and technology roadmap, outlining its plan to navigate the energy transition and capitalize on market growth.

With $1B in funding and a new virtual cell model, Xaira Therapeutics hires a top dealmaker to turn its AI prowess into pharma partnerships.

Austin startup Scalvy has secured major Series A funding to deploy its radical new power delivery platform for AI data centers and the energy grid.

A record $606.5M net income, fueled by a major divestment, funds a $200M dividend and a strategic merger creating a global IT powerhouse.

GlobalTech Corporation's move to the OTCQB market is more than a formality; it's a calculated step to boost transparency and fuel its AI-driven Nasdaq ambition.

Tired of marketing and finance debating whose numbers are right? A new warehouse-native approach promises to end the data wars for good.

The company's B-cell cancer assay has achieved stringent IVDR certification, navigating a complex landscape and gaining a key edge in Europe's market.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

A new partnership uses advanced AI to find unused grid capacity, slashing data center connection times from years to months and accelerating economic growth.

As oncologists warn of supplement risks, one company founded by a doctor and caregiver aims to provide a safer, transparent path for cancer survivors.